Gene therapy 'incubator' to be built by 2029 in Lake Success Biogenesis Park, officials say
The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...
FierceBiotech9h
Ocuphire Pharma to transform into gene-therapy-focused biotech via Opus acquisition
Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see ...
BioSpace4h
Sangamo’s Fabry Gene Therapy Could Hit Market 3 Years Earlier With FDA Accelerated Approval Pathway
The regulator agreed to allow Sangamo Therapeutics to use data to seek accelerated approval for its Fabry gene therapy ...
$430 million cell and gene therapy center is coming to Long Island. Here's more on New York Biogenesis Park.
Gov. Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be ...
Pharmaceutical Technology5h
Ocuphire and Opus Genetics merge to develop IRD gene therapy
Ocuphire Pharma has announced the acquisition of Opus Genetics to develop gene therapies for inherited retinal diseases (IRDs ...
Hosted on MSN20h
MIND Diet and Cognitive Decline; Gene Therapy for Parkinson's; Curbing MS Fatigue
The MIND diet was associated with slower cognitive decline in both Black and white older adults, but relationships appeared ...
FiercePharma3h
Roche's Vabysmo will rise above Eylea biosim threat, exec says, as DMD gene therapy Elevidys delivers sales surprise
By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...
FierceBiotech1d
Sangamo slashes time to market for Fabry gene therapy as FDA agrees to accelerated approval package
The biotech engaged with the FDA on alternative pathways to approval after seeing safety and efficacy data from the phase 1/2 ...
Long Island Business News18h
$430M cell and gene therapy hub planned for Long Island
Visiting Nassau County on Tuesday, Gov. Kathy Hochul announced plans for the New York BioGenesis Park, a $430 million, ...
Northwest Arkansas Democrat Gazette1d
$1.8 Million awarded to UA professor to study durability of gene therapy
The National Institutes of Health has awarded an assistant professor of biomedical engineering about $1.8 million to study ...
Medpage Today on MSN1d
Evidence of Durable Vision Improvement With Gene Therapy for Retinitis Pigmentosa
CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...
Life Without Sickle Cell Beckons Boy Who Completed Gene Therapy
After 44 days, Kendric Cromer, 12, left the hospital. While his family feels fortunate that he was the first to receive a treatment, their difficult experiences hint at what others will be up against.